 |
 |

Rebuttal
Paula M. Trief, PhD;
Richard A. Ellison, JD
Arch Intern Med. 2008;168(8):803.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Littenberg and MacLean make very good arguments for the value of disease registries. We agree that registries are highly useful to monitor trends, look for patterns, and provide data for research. We also agree that chronic diseases, like diabetes, exact a tremendous toll on individuals, communities, and society. Thus, it is not surprising that there already exist many diabetes registries that are used for the goals outlined, and other registries could be developed that would be benign. All of the stated goals can be achieved using deidentified data. The registry that is our focus is one that uses the information to contact patients and their physicians directly about their health status. The authors never forthrightly address the significant risks we believe are associated with this opt-out registry, including risks to privacy, to the physician-patient relationship, to potential discrimination, and to patient autonomy.
. . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLES
Mandated Diabetes Registries Will Benefit Persons With Diabetes
Benjamin Littenberg and Charles D. MacLean
Arch Intern Med. 2008;168(8):797-799.
EXTRACT
| FULL TEXT
Mandated Diabetes Registries Will Not Benefit Persons With Diabetes
Paula M. Trief and Richard A. Ellison
Arch Intern Med. 2008;168(8):799-802.
EXTRACT
| FULL TEXT
Rebuttal
Benjamin Littenberg and Charles D. MacLean
Arch Intern Med. 2008;168(8):802-803.
EXTRACT
| FULL TEXT
|